Race of GLPS: Impact on Weight and Glycemic Control on Type 2 Diabetes with Semaglutide Versus Liraglutide

OBJECTIVES Semaglutide is a glucagon-like peptide-1 receptor agonist that improves glycemic control and reduces body weight in patients with type 2 diabetes. This study aimed to evaluate the effect of Semaglutide with standard Metformin on glycemic control and BMI after 3 and 6 months of treatmen...

Full description

Saved in:
Bibliographic Details
Main Authors: Noha Hafeez, Fatima Jehanghir, Aroosa Altaf, Huma Akbar Jafri, Tariq Adnan, Faiza Rani Ahmed, Naureen Kazim
Format: Article
Language:English
Published: Gandhara University 2024-12-01
Series:Journal of Gandhara Medical and Dental Sciences
Subjects:
Online Access:https://jgmds.org.pk/index.php/JGMDS/article/view/633
Tags: Add Tag
No Tags, Be the first to tag this record!